Totale waarde Cencora, Inc.
Aandelen
COR
US03073E1055
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
234,53 USD | -2,78% | -1,26% | +14,19% |
Bedrijfswaardering: Cencora, Inc.
Fiscaal tijdperk: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Marktkapitalisatie 1 | 17.151 | 19.785 | 24.820 | 28.048 | 36.148 | 45.970 | - | - |
Variatie | - | 15,36% | 25,45% | 13,01% | 28,88% | 27,17% | - | - |
Bedrijfswaarde 1 | 17.950 | 19.307 | 28.957 | 30.363 | 38.343 | 46.909 | 45.670 | 42.874 |
Variatie | - | 7,56% | 49,98% | 4,86% | 26,28% | 22,34% | -2,64% | -6,12% |
K/w-verhouding | 20,4x | -5,82x | 16,2x | 16,8x | 21,1x | 22,9x | 19,7x | 17,3x |
PBR-ratio | 5,91x | -19,4x | 111x | 401x | 54,2x | 34,7x | 15,9x | 9,59x |
PEG | - | 0x | -0x | 1,91x | 3,46x | 1,1x | 1,2x | 1,3x |
Marktkapitalisatie/omzet | 0,1x | 0,1x | 0,12x | 0,12x | 0,14x | 0,16x | 0,15x | 0,14x |
Bedrijfswaarde/omzet | 0,1x | 0,1x | 0,14x | 0,13x | 0,15x | 0,16x | 0,15x | 0,13x |
Bedrijfswaarde/EBITDA | 7,63x | 7,77x | 9,73x | 8,55x | 10,4x | 11,6x | 10,6x | 9,39x |
Bedrijfswaarde/EBIT | 8,75x | 8,76x | 10,9x | 9,6x | 11,7x | 12,9x | 11,8x | 10,5x |
Bedrijfswaarde/FCF | 8,83x | 10,5x | 13x | 13,8x | 11,1x | 17,7x | 16x | 13,1x |
FCF Yield | 11,3% | 9,52% | 7,7% | 7,27% | 9,01% | 5,64% | 6,23% | 7,63% |
Dividend per aandeel 2 | 1,6 | 1,66 | 1,78 | 1,84 | 1,94 | 2,067 | 2,124 | 2,215 |
Rendement | 1,94% | 1,71% | 1,49% | 1,36% | 1,08% | 0,88% | 0,91% | 0,94% |
WPA 2 | 4,04 | -16,65 | 7,39 | 8,04 | 8,53 | 10,25 | 11,91 | 13,55 |
Uitkeringspercentage | 39,6% | -9,97% | 24,1% | 22,9% | 22,7% | 20,2% | 17,8% | 16,4% |
Omzet 1 | 179.589 | 189.894 | 213.989 | 238.587 | 262.173 | 292.656 | 313.200 | 333.101 |
EBITDA 1 | 2.354 | 2.485 | 2.977 | 3.553 | 3.702 | 4.051 | 4.307 | 4.566 |
EBIT 1 | 2.051 | 2.204 | 2.648 | 3.163 | 3.289 | 3.638 | 3.859 | 4.084 |
Nettowinst (verlies) 1 | 855,4 | -3.409 | 1.540 | 1.699 | 1.745 | 2.030 | 2.274 | 2.530 |
Nettoschuld 1 | 798,7 | -478,2 | 4.137 | 2.315 | 2.195 | 939,7 | -299,7 | -3.096 |
Referentiekoers 2 | 82,33 | 96,92 | 119,45 | 135,33 | 179,97 | 234,53 | 234,53 | 234,53 |
Aantal aandelen (in duizend) | 208.326 | 204.142 | 207.787 | 207.258 | 200.854 | 196.008 | - | - |
Datum van publicatie | 7/11/19 | 5/11/20 | 4/11/21 | 3/11/22 | 2/11/23 | - | - | - |
K/w-verhouding, Gedetailleerde evolutie
Toevoegen aan een lijst 0 geselecteerde | K/w-verhouding | EV/omzet | Beurskap. / EBITDA | Dividendrendement (Y) | Kapi. ($) | |
---|---|---|---|---|---|---|
22.88x | 0.16x | 11.58x | +0.88% | 45,97 mld. | ||
34.87x | 5.06x | 19.77x | +1.88% | 206 mld. | ||
22.01x | 4.01x | 13.89x | +3.17% | 114 mld. | ||
34.29x | 3.98x | 14.12x | +1.61% | 66,85 mld. | ||
32.62x | 7.22x | 20.37x | +0.63% | 47,06 mld. | ||
35.4x | 8.17x | 25.41x | -.--% | 29,36 mld. | ||
41.74x | 7.2x | 24.73x | -.--% | 27,63 mld. | ||
30.17x | 3.82x | 15.44x | +0.99% | 27,47 mld. | ||
35.3x | 4.75x | 16.99x | +0.95% | 23,83 mld. | ||
22.37x | 3.41x | 10.02x | +0.91% | 21,64 mld. | ||
Gemiddelde | 31,16x | 4,78x | 17,23x | +1,10% | 60,9 mld. | |
Gewogen gemiddelde per kap. | 31,02x | 4,66x | 17,33x | +1,63% |